$ Value
$0
Shares
63,636
Price
$0
Filed
Jul 3
Insider
Name
Agah Ramtin
Title
Chief Medical Officer
CIK
0001862617
Roles
Transaction Details
Transaction Date
2025-07-01
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
63,636
Footnotes
Represents an award of 63,636 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the "Plan") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025. The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035.
Filing Info
Agah Ramtin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-03 | RNXT | A | $0 |
| 2026-01-21 | RNXT | ▲ | $10K |
| 2025-12-31 | RNXT | ▲ | $8K |
| 2025-12-30 | RNXT | ▲ | $169 |
| 2025-12-16 | RNXT | ▲ | $10K |
| 2025-12-05 | RNXT | ▲ | $10K |
| 2025-11-24 | RNXT | ▲ | $10K |
| 2025-11-21 | RNXT | ▲ | $8K |
| 2025-07-01 | RNXT | A | $0 |
| 2025-06-05 | RNXT | ▲ | $29K ★ |
Other Insiders at RNXT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
VOLL MARK
Chief Financial Officer
|
— | — | 2026-04-03 |
| Marton Laurence | — | — | 2026-03-20 |
|
Bagai Shaun
Chief Executive Officer
|
— | — | 2026-04-03 |
|
Agah Ramtin
Chief Medical Officer
|
— | — | 2026-04-03 |
|
Gentry Leesa
Chief Clinical Officer
|
— | — | 2026-04-03 |